TFSA Investors: If You Have $6,000, Buy These 2 TSX Stocks Right Now

Here’s why Canadians can look to invest in Docebo (TSX:DCBO) stock and Gildan Activewear (TSX:GIL)(NYSE:GIL) stock right now.

| More on:
IMAGE OF A NOTEBOOK WITH TFSA WRITTEN ON IT

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

A volatile market provides investors a chance to make money. For example, the ideal time to invest in Canadian equities this year was in mid-March when markets bottomed out. The iShares S&P/TSX 60 Index ETF has rebounded 40% in fewer than three months.

There may be a market crash on the horizon. But as we know, it’s impossible to time the markets, and if the market recovery continues, investors will not get a chance to buy the dip, at least in the near future.

You can instead look to buy stocks that continue to trade at a discount. The TFSA (Tax-Free Savings Account) contribution room for 2020 stands at $6,000. Canadians can add the below TSX stocks to their TFSA portfolio and benefit from tax-free gains.

Why Docebo is ideal for your TFSA

As any withdrawals from the TFSA are tax-free, it makes sense to leverage this benefit and invest in growth stocks. Small-cap growth stocks have the potential to create massive wealth over time.

Canada’s Docebo (TSX:DCBO) is one such stock that will soon become an investor favourite. The company has a market cap of $787 million and is fast gaining traction in the enterprise e-learning space.

Docebo’s platform provides companies with a way to access e-learning solutions. This cloud-based solution is used by 1,900 organizations, including Appian, Walmart, and Thomson Reuters.

Docebo stock is trading at $27.65 and has gained 170% since touching a record low of $10.3 in March 2020. Analysts tracking Docebo expect its sales to reach $78.5 million in 2021, up from $58.7 million in 2019. This means the stock has a market cap to forward 2021 sales multiple of 10, which is reasonable considering its growth rates.

Further, Docebo is also expected to improve earnings from -$0.49 in 2019 to -$0.08 in 2021. It is forecast to reach non-GAAP profitability by 2022. Docebo continues to focus on organic growth and new product offerings to expand the customer base and is one of the top picks for long-term investors.

A beaten-down retail company

Retail stocks have been decimated in recent times due to countrywide lockdowns and lower consumer spending. Shares of Canada-based clothing manufacturer, Gildan Activewear (TSX:GIL)(NYSE:GIL) are trading at $24.08, which is 55% below its 52-week high. Similar to most other stocks, Gildan has also made a comeback since March 2020 and is up 90% since the sell-off.

Analysts expect the company to post a sales decline of 40% in 2020. Sales were down 26% in Q1 and are estimated to fall 68% in Q2 and 42% in Q3. However, revenue is forecast to rise by 32.4% to US$2.25 billion in 2021. With a market cap of US$3.55 billion, the stock has a forward price-to-sales multiple of just 1.6.

The massive revenue decline will result in an 86% fall in profit margins. Analysts then expect Gildan to improve earnings by 422% in 2021 to US$1.2, indicating a price to 2021 earnings of 15.

Foolish takeaway

The recent market pullback is an opportunity to buy quality stocks at a lower valuation. A $6,000 investment right now in these two stocks can multiply your wealth in the upcoming decade.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Tom Gardner owns shares of Appian. The Motley Fool owns shares of and recommends Appian. The Motley Fool recommends GILDAN ACTIVEWEAR INC. Fool contributor Aditya Raghunath has no position in any of the stocks mentioned.

More on Tech Stocks

A worker uses a double monitor computer screen in an office.
Tech Stocks

Why Shopify Stock Sold Off Last Week

Shopify (TSX:SHOP) sold off heavily last week. A bad earnings release may have been the culprit.

Read more »

Hand arranging wood block stacking as step stair with arrow up.
Tech Stocks

2 Phenomenal Growth Stocks Down 30-60% That Could Rally in the Next Bull Market

Is it time to buy growth stocks? The worst of the interest rate hike and inflation is over, and now…

Read more »

stock market
Tech Stocks

2 Best Tech Stocks to Buy Before the Next Bull Market

Tech stocks such as Roku and Nuvei can help long-term investors generate outsized gains in 2023 and beyond.

Read more »

Wireless technology
Tech Stocks

Tucows Stock Trades Near its 6-Year Low: Is it a Buy?  

Tucows stock fell 63% in the tech stock sell-off and has failed to show any recovery. Is this domain and…

Read more »

Male IT Specialist Holds Laptop and Discusses Work with Female Server Technician. They're Standing in Data Center, Rack Server Cabinet with Cloud Server Icon and Visualization
Tech Stocks

Is Converge Stock a Buy?

A relatively new tech stock could soar higher with the pause in rate hikes, although a resumption of the cycle…

Read more »

online shopping
Tech Stocks

Up by 25%: Is Shopify Stock Finally a Buy in 2023?

The strong rebound in the TSX’s top tech stock remains uncertain. Investors will have to wait before it delivers stellar…

Read more »

Businessman holding AI cloud
Tech Stocks

2 TSX Tech Stocks Innovating Hard in AI

Shopify (TSX:SHOP) stock and another intriguing Canadian gem make good use of AI technologies.

Read more »

worry concern
Tech Stocks

Shopify Stock: Incredible Bargain or Deceptive Trap?

Shopify has quickly shifted from a market darling to something else. Is it a safe buy or risqué bet?

Read more »